| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
INSERM, U-135, Unité de Recherches Hormones Gènes et Reproduction, Hôpital de Bicêtre (B.K., M.M., E.M., N.d.R.), Le-Kremlin-Bicêtre, 94270 Paris, France; Pediatric Endocrinology, University Childrens Hospital (B.K.), and Division of Endocrinology, Department of Internal Medicine (W.K., L.L.), University of Ulm, D-89075 Ulm, Germany; and Institute of Molecular Pharmacology (R.K.), D-13125 Berlin, Germany
Address all correspondence and requests for reprints to: Dr. Nicolas de Roux, INSERM, U-135, Hôpital de Bicêtre, 78 rue du Général Leclerc, F 94270 Le-Kremlin-Bicêtre, France. E-mail: nicolas.deroux{at}bct.ap-hop-paris.fr.
Mutations of the GnRH receptor have been recognized as a cause of familial gonadotropin deficiency. We here identify and functionally characterize a novel human GnRH receptor variant bearing an Ala171Thr substitution located at transmembrane helix 4 (TMH4). The affected kindred displays severe hypogonadotropic hypogonadism. After in vitro expression in human embryonic kidney 293T cells, the Ala171Thr mutant GnRH receptor exhibited a lack of phospholipase C activity in signal transduction. Specific receptor binding of 125I-labeled GnRH ligand was undetectable in Ala171Thr GnRH receptor-transfected cells. Molecular modeling and dynamic simulation of the Ala171Thr GnRH receptor suggests the introduction of a stable hydrogen bond between residue Thr171 and Tyr119 side-chains at a distance of 2 Å. Although spatially distant from the GnRH ligand-binding site, this hydrogen bond impedes conformational mobility of the TMH3 and TMH4 domains required for sequential ligand binding and receptor activation, thus stabilizing the GnRH receptor in its inactive conformation. Receptor structure modeling and functional data provide a comprehensive molecular view of how mutation Ala171Thr causes a complete loss of GnRH receptor function.
This work was supported in part by a European Society of Pediatric Endocrinology Research Fellowship (to B.K.) sponsored by Novo Nordisk A/S, and by Zentaris AG (Frankfurt, Germany; to R.K.).
Abbreviations: ECL, Extracellular loop; EGFP, enhanced green fluorescent protein; GFP, green fluorescent protein; GnRHR, GnRH receptor; GPCR, G protein-coupled receptor; PLC, phospholipase C; TMH, transmembrane helix; WT, wild type.
This article has been cited by other articles:
![]() |
The ESHRE Capri Workshop Group Genetic aspects of female reproduction Hum. Reprod. Update, April 2, 2008; (2008) dmn009v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lanfranco, J. Gromoll, S. von Eckardstein, E. M Herding, E. Nieschlag, and M. Simoni Role of sequence variations of the GnRH receptor and G protein-coupled receptor 54 gene in male idiopathic hypogonadotropic hypogonadism Eur. J. Endocrinol., December 1, 2005; 153(6): 845 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Karges, G. Krause, J. Homoki, K.-M. Debatin, N. de Roux, and W. Karges TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5 J. Endocrinol., August 1, 2005; 186(2): 377 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Knollman, J. A. Janovick, S. P. Brothers, and P. M. Conn Parallel Regulation of Membrane Trafficking and Dominant-negative Effects by Misrouted Gonadotropin-releasing Hormone Receptor Mutants J. Biol. Chem., July 1, 2005; 280(26): 24506 - 24514. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leanos-Miranda, A. Ulloa-Aguirre, J. A. Janovick, and P. M. Conn In Vitro Coexpression and Pharmacological Rescue of Mutant Gonadotropin-Releasing Hormone Receptors Causing Hypogonadotropic Hypogonadism in Humans Expressing Compound Heterozygous Alleles J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3001 - 3008. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Cheng and P. C. K. Leung Molecular Biology of Gonadotropin-Releasing Hormone (GnRH)-I, GnRH-II, and Their Receptors in Humans Endocr. Rev., April 1, 2005; 26(2): 283 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. U. Meysing, H. Kanasaki, G. Y. Bedecarrats, J. S. Acierno Jr., P. M. Conn, K. A. Martin, S. B. Seminara, J. E. Hall, W. F. Crowley Jr., and U. B. Kaiser GNRHR Mutations in a Woman with Idiopathic Hypogonadotropic Hypogonadism Highlight the Differential Sensitivity of Luteinizing Hormone and Follicle-Stimulating Hormone to Gonadotropin-Releasing Hormone J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3189 - 3198. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Millar, Z.-L. Lu, A. J. Pawson, C. A. Flanagan, K. Morgan, and S. R. Maudsley Gonadotropin-Releasing Hormone Receptors Endocr. Rev., April 1, 2004; 25(2): 235 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ulloa-Aguirre, J. A. Janovick, A. Leanos-Miranda, and P. M. Conn Misrouted cell surface GnRH receptors as a disease aetiology for congenital isolated hypogonadotrophic hypogonadism Hum. Reprod. Update, March 1, 2004; 10(2): 177 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Brothers, J. A. Janovick, and P. M. Conn Unexpected Effects of Epitope and Chimeric Tags on Gonadotropin-Releasing Hormone Receptors: Implications for Understanding the Molecular Etiology of Hypogonadotropic Hypogonadism J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6107 - 6112. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |